Suppr超能文献

肝门部胆管癌的外科治疗。单中心经验。

Surgical treatment in proximal bile duct cancer. A single-center experience.

作者信息

Pichlmayr R, Weimann A, Klempnauer J, Oldhafer K J, Maschek H, Tusch G, Ringe B

机构信息

Medizinische Hochschule Hannover, Institut für Pathologie, Germany.

出版信息

Ann Surg. 1996 Nov;224(5):628-38. doi: 10.1097/00000658-199611000-00007.

Abstract

OBJECTIVES

The authors evaluated the experience and results of a single center in surgical treatment of proximal bile duct carcinoma.

SUMMARY BACKGROUND DATA

Whenever feasible, surgery is the appropriate treatment in proximal bile duct carcinoma. To improve survival rates and with special regard to liver transplantation, the extent of surgical radicalness remains an open issue.

PATIENTS AND METHODS

Retrospective analysis of 249 patients who underwent surgery for proximal bile duct carcinoma via the following procedures: resection (n = 125), liver transplantation (n = 25), and exploratory laparotomy (n = 99). Survival rates were calculated according to the Kaplan-Meier method, uni- and multivariate analysis of prognostic factors, and log rank test (p < 0.05).

RESULTS

Survival rates after resection and liver transplantation are correlated with international Union Against Cancer (UICC) tumor stage (resection: overall 5-year, 27.1%; stage I and II, 41.9%; stage IV, 20.7%; liver transplantation: overall 5-year, 17.1%; stage I and II, 37.8%; stage IV, 5.8%). Significant univariate prognostic factors for survival after liver resection were lymph node involvement (N category), tumor stage, tumor-free margins, and vascular invasion; for transplantation, they were local tumor extent, N category, tumor stage, and infiltration of liver parenchyma. For resection and transplantation, a multivariate analysis showed prognostic significance of tumor stage and tumor-free margins.

CONCLUSION

Resection remains the treatment of choice in proximal bile duct carcinoma. Whenever possible, decisions about resectability should be made during laparotomy. With regard to the observation of long-term survivors, liver transplantation still can be justified in selected patients with stage II carcinoma. It is unknown whether more radical procedures, such as liver transplantation combined with multivisceral resections, will lead to better outcome in advanced stages. With regard to palliation, surgical drainage of the biliary system performed as hepatojejunostomy can be recommended.

摘要

目的

作者评估了单中心治疗肝门部胆管癌的经验及结果。

总结背景数据

只要可行,手术是肝门部胆管癌的适宜治疗方法。为提高生存率,尤其考虑到肝移植,手术根治程度仍是一个有待解决的问题。

患者与方法

对249例行肝门部胆管癌手术的患者进行回顾性分析,手术方式包括:切除术(n = 125)、肝移植术(n = 25)和剖腹探查术(n = 99)。根据Kaplan-Meier法计算生存率,对预后因素进行单因素和多因素分析,并进行对数秩检验(p < 0.05)。

结果

切除术后和肝移植术后的生存率与国际抗癌联盟(UICC)肿瘤分期相关(切除术:总体5年生存率为27.1%;Ⅰ期和Ⅱ期为41.9%;Ⅳ期为20.7%;肝移植术:总体5年生存率为17.1%;Ⅰ期和Ⅱ期为37.8%;Ⅳ期为5.8%)。肝切除术后生存的显著单因素预后因素为淋巴结受累(N分期)、肿瘤分期、切缘阴性和血管侵犯;对于肝移植,这些因素为局部肿瘤范围、N分期、肿瘤分期和肝实质浸润。对于切除术和肝移植术,多因素分析显示肿瘤分期和切缘阴性具有预后意义。

结论

切除术仍是肝门部胆管癌的首选治疗方法。只要有可能,应在剖腹手术期间做出关于可切除性的决定。关于长期生存者的观察,对于部分Ⅱ期癌患者,肝移植仍有其合理性。对于晚期患者,诸如肝移植联合多脏器切除等更激进的手术是否会带来更好的结果尚不清楚。对于姑息治疗,可推荐行肝空肠吻合术进行胆道系统的手术引流。

相似文献

7
Surgery for hilar cholangiocarcinoma: the Leeds experience.肝门部胆管癌手术:利兹的经验
Eur J Surg Oncol. 2008 Jul;34(7):787-94. doi: 10.1016/j.ejso.2007.10.005. Epub 2007 Nov 26.

引用本文的文献

4
A Case of Cholecystitis Camouflaging Cholangiocarcinoma.胆囊炎伪装成胆管癌1例。
Cureus. 2024 Mar 3;16(3):e55448. doi: 10.7759/cureus.55448. eCollection 2024 Mar.
10
Can the Limits of Liver Transplantation Be Expanded in Perihilar Cholangiocarcinoma?肝门部胆管癌的肝移植极限能否扩大?
J Gastrointest Cancer. 2022 Dec;53(4):1104-1112. doi: 10.1007/s12029-021-00735-6. Epub 2021 Nov 5.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验